Neuropharmacology and genetic aspects of CNS function
Neuropharmacology is the learning of the effects of drugs on the nervous system and targeting to develop compounds to benefit humans with psychiatric and neurological disease. These contain Huntington's disease, myotonic dystrophy, Rett syndrome and fragile X syndrome. In these cases, the single-gene mutation causes certain neurons in the central and peripheral nervous system to develop abnormally and function poorly.
Related Conference of Neuropharmacology and genetic aspects of CNS function
September 28-29, 2026
30th International Conference on Neuropharmacology and Neurochemistry
Rome, Italy

